Rasna Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.007; its P/E ratio is -1.62; Rasna Therapeutics is scheduled to report earnings on May 10, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -124.32K	$ 131.61K	$ -100.32K	$ 3.81M	$ -138.14K
EBITDA	$ -109.46K	$ 135.49K	$ -100.32K	$ 3.97M	$ -121.96K
Net Income Common Stockholders	$ -147.64K	$ -58.33K	$ -105.16K	$ 3.80M	$ -149.84K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 19.18K	$ 74.99K	$ 2.47K	$ 2.22K	$ 47.55K
Total Assets	$ 26.18K	$ 95.66K	$ 37.06K	$ 52.30K	$ 60.58K
Total Debt	$ 225.70K	$ 210.97K	$ 215.51K	$ 220.40K	$ 183.22K
Net Debt	$ 206.52K	$ 135.99K	$ 213.03K	$ 218.18K	$ 135.66K
Total Liabilities	$ 1.74M	$ 2.05M	$ 2.01M	$ 1.92M	$ 1.87M
Stockholders Equity	$ -2.10M	$ -1.96M	$ -1.98M	$ -1.87M	$ -1.81M
Cash Flow	-
Free Cash Flow	$ -47.29K	$ 6.65K	$ 9.99K	$ -23.77K	$ -1.39K
Operating Cash Flow	$ -47.29K	$ 6.65K	$ 9.99K	$ -23.77K	$ -1.39K
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	$ -8.51K	$ 65.86K	$ -9.74K	$ -21.57K	$ 9.58K

Currency in USD

Rasna Therapeutics Earnings and Revenue History

Income Statement >

Rasna Therapeutics Debt to Assets

Balance Sheet >

Rasna Therapeutics Cash Flow

Cash Flow >

Rasna Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing